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Background: Cancer of the oral cavity combined with oropharyngeal cancer is the sixth leading cause of death for 
cancer worldwide. Surgery remains the standard treatment for this disease in early clinical and locally advanced 
stages. Numerous studies have shown that laser management is useful for premalignant lesions in the oral cavity; 
however, there is no conclusive evidence that its use is appropriate in cancer of the oral cavity and that results are 
comparable with traditional surgery. The objective of this study is to determine cancer control after wide local 
resection with CO2 laser for oral malignant neoplasms. 
Material and Methods: Retrospective study in patients with tumors of the oral cavity who were considered for 
surgical resection with CO2 laser from January 2006-December 2015. Demographic data, treatment modalities, 
histopathological diagnosis and clinical stage variables were obtained. All resections were done with the use of 
the microspot. Patients with cancer of the tongue were not included because a specific protocol for these patients 
does exist in our institution. 
Results: There were twenty patients, 10 male and 10 female with a average age of 58 years (range: 20-92 years). 
Mean age was 53.5 years for females and 63 years for males. Twelve (60%) patients are alive and disease free and 
four (20%) were lost free of disease. 
Conclusions: CO2 laser is an acceptable surgical method for the management of small lesions in the oral cavity. We 
cannot rule out that small lesions of the oral cavity with positive neck could be managed in this manner, adding 
treatment to the neck, producing an adequate local regional control. However, this hypothesis requires additional 
studies. 
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Introduction
Cancer of the oral cavity in combination with cancer 
of the oropharynx is the sixth cause of death of can-
cer worldwide. Despite improvements in management, 
5-year survival is only 45−50%. The occurrence of this 
cancer has been linked mainly to the use of tobacco, 
betel nut and alcohol consumption. There are different 
prognostic factors such as the primary site, lymph nodes 
involved, tumor thickness and surgical margins (1). The 
standard treatment for this type of cancer is radical 
surgery and preservation of aesthetics and function as 
much as possible with wide macroscopic tridimensional 
margins from 15 mm onwards to obtain a microscopic 
margin >5 mm (2-4). Surgery can be performed with 
a traditional scalpel, cryotherapy, or with electrocau-
tery with laser (5-9). Laser has been used in surgery 
since the 1960s. Advantages include clean margins and 
decreased damage to the surrounding resected tissue. 
With assistance of microscope resection is more appar-
ent, which is not the case scalpel or other type of in-
strument where the resection is greater (10-13). Multiple 
studies have proven that laser management is adequate 
in premalignant lesions of the oral cavity (14); however, 
no conclusive evidence is available that its use is ap-
propriate in cancer of the oral cavity and that the results 
with its use are comparable to those with traditional sur-
gery. The objective of this study is to determine if wide 
local resection of cancer of the oral cavity with a CO2 
laser offers adequate cancer control. 
Material and Methods 
A retrospective study was carried out including patients 
with tumors of the oral cavity who were considered 
for surgical resection with the CO2 laser from January 
2006−December 2015. Variables obtained were treat-
ment, histopathological diagnosis and clinical stages. 
All resections were done using microscope and the mi-
crospot. This study did not include patients with cancer 
of the tongue because a protocol for these types of pa-
tients already exists in our institution. Survival staging 
was not established for this group due to the variety of 
histological diagnoses and prognoses (Table 1). All pa-
tients in our study were treated as outpatients or had a 
1-day hospital stay. 
Results
Twenty patients were included: 10 males and 10 females 
with a mean age of 58 years (20−92 years). The mean 
age for females was 53.5 years and for males was 63 
years. Clinical features are shown in Table 1. Table 2 
shows age, subsite, histologic types of tumors, surgi-
cal margins, actual stage (at the time of the study) and 
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Table 1. Clinical features.
Discussion
Management of oral cavity tumors with CO2 laser is not 
a standard treatment. The existing experience is rather 
limited and the equipment required to carry out the pro-
cedure is expensive, particularly when performed under 
the microscope. Advantages of surgical treatment with 
CO2 laser in diseases of the oral cavity include minimal 
damage to the adjacent tissues, reduction of the acute 
inflammatory reaction, and decrease in the activity of 
myofibroblasts which leads to a reduced contraction of 
tissue in scarring (15). In addition, patients managed 
with this type of approach have less postoperative pain, 
as it is a less invasive surgery in which no sutures are 
used and complex reconstruction using free flaps is not 
required (16). Tuncer et al. (17) demonstrated  these ad-
vantages where they compared conventional surgery 
with laser surgery in oral cavity disease. The authors 
evaluated the effect of thermal damage in regard to the 
histopathological diagnosis, pain control and postopera-
tive complications and demonstrated that thermal dam-
age does not have an adverse effect with respect to the 
histopathological diagnosis. There was also better pain 
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control with the use of the laser and there were no in-
tra- or postoperative complications. It is important to 
emphasize that, in our series, despite having extensive 
resections, patients only remained hospitalized for 1 
day, which is an additional advantage when compared 
with those who have complex reconstructions along 
with prolonged hospital stay. Surgery remains as the 
treatment of choice for cancer of the oral cavity in early 
clinical stages. Although there is information about 
the usefulness of the CO2 laser in the treatment of be-
nign and premalignant lesions, there is little evidence 
to demonstrate if this type of approach is appropriate 
for management of malignant lesions of the oral cavity, 
particularly epidermoid carcinoma. However, we pres-
ent a case series with diverse pathologies that included 
six cases of epidermoid carcinoma and all patients un-
derwent wide local excision. Only one case had a posi-
tive margin in the definitive histopathology; however, 
this had no impact on recurrence as the patient had no 
recurrence during follow-up. 
Jerjes et al. (16) carried out a prospective study to exam-
ine results after CO2 laser resection in T1/T2 N0 epider-
moid carcinoma in order to determine the disease-free 
period and survival in 90 patients. The most frequently 
affected sites in these patients were tongue and floor of 
the mouth and the most common clinical presentation 
was as ulcers of the oral mucosa. Eighty-one patients 
presented with T1N0 and nine patients T2N0. Histo-
pathological analysis revealed that half of the patients 
had moderately differentiated epidermoid carcinoma, 
18 patients moderate to poorly differentiated and 19 
patients poorly differentiated carcinoma. Seventy-three 
patients had complete resection with 11 cases of recur-
rence (12%). Three-year survival was 86.7%. Twelve 
patients died during follow-up, nine of whom died due 
to causes unrelated to the cancer, two due to local re-
gional recurrence and one due to metastatic pulmonary 
disease. When compared with our series, 95% of our 
margins were negative; however, in our series the his-
tologies were diverse which are associated with differ-
ent prognosis. Despite this, 60% of our patients are still 
alive and free of disease; in addition, there were four 
patients lost without disease. 
Three out of the six cases of epidermoid carcinoma in-
cluded in our series were treated with selective neck 
dissection (SND). The first one was managed with 
CO2 laser resection. At 1-year follow- up, the patient 
presented with a new lesion. Radical surgery with in-
ferior maxillectomy plus SND at levels I−III was car-
ried out. Histopathological report was adenocarcinoma 
of the salivary gland and negative lymph nodes. This 
case may represent a second primary tumor. The second 
patient underwent laser resection (oral mucosa subsite) 
plus SND at levels I−III and had one node positive for 
malignancy. The patient was referred for adjuvant ra-
diotherapy (RT) (72 Gy). This patient was lost to follow-
up. The third case was similarly referred for laser exci-
sion of the primary tumor with SND at levels I−III and 
has demonstrated no evidence of recurrence.  
Three cases had mucosal melanoma. One presented 
multiple melanotic lesions during follow-up and were 
resected on five occasions with CO2 laser with histo-
pathological diagnosis of melanosis. At 8 years of fol-
low-up (2015), metastatic disease in the mediastinum 
was documented by positron emission tomography. The 
patient continues with follow-up and is being treated 
with palliative CT. Another patient with clinical stage 
III melanoma was referred for laser surgery of mela-
notic lesions on five occasions. Only the first oral le-
sion was reported as melanoma. The remainder were 
reported as melanosis. At 8 years of follow-up the pa-
tient presented with recurrence in the palate and neck 
and required management with total palatectomy and 
neck dissection, receiving adjuvant RT and CT. The pa-
tient presented disease progression to the central ner-
vous system and bone and died of disease. The third 
patient with melanoma had recurrence of the melanoma 
and was referred for local excision with CO2 laser. His-
topathological diagnosis was melanoma in situ. Cur-
rently the patient is reported with hard palate melanosis 
without signs of malignancy. In our experience, we do 
not perform surgical excision of melanotic macules and 
avoid mutilating resections in melanoma of the head 
and neck because patients do not die from local disease. 
Local recurrences are the rule in which excisions are 
done on multiple occasions until the patients finally die 
due to metastatic disease. Five-year survival is 4.5−29% 
despite aggressive treatment of the disease (18). 
There were nine cases with tumors of the minor salivary 
glands, three of which corresponded to pleomorphic ad-
enomas, four mucoepidermoid carcinomas and two ad-
enoid cystic carcinomas. There are no previous reports 
of treatment with CO2 laser for these types of salivary 
gland tumors; however, in our series all cases have re-
mained disease-free and none was submitted to neck 
dissection. We previously demonstrated that neck dis-
section in adenoid cystic carcinoma is only therapeuti-
cally useful (19). 
The first one had two patients with diagnosis of sarco-
ma. The first has a myofibroblastic sarcoma of the floor 
of the mouth and was referred for surgery with laser 
excision and presented persistence of the disease. The 
patient did not accept radical treatment. The second pa-
tient had a diagnosis of monophasic synovial sarcoma 
and was referred for laser surgery treatment, and sur-
gical bed (bone) was reported with neoplasm. Radical 
surgery was decided upon with a partial palatectomy. 
The histopathological report of the palatectomy was 
negative for malignancy. There are no reports in the 
literature for treatment of this type of histology with 
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CO2 laser; however, due to the biology of this type of 
neoplasm, patient choice must be very selective. 
Conclusions
Evolution of oncology has produced an effect on the de-
cision to perform less invasive surgical procedures. It 
has been demonstrated that the results of using CO2 la-
ser are in a significative number comparable with those 
obtained with radical surgery. CO2 laser demonstrates 
that this is an acceptable surgical method for the man-
agement of small lesions of the oral cavity. In fact, we 
do not rule out the notion that small lesions of the oral 
cavity with positive neck can be managed in this way, 
adding treatment to the neck, producing appropriate 
local regional control. However, the limitation of this 
work is that it is a retrospective study and further stud-
ies are required to better estimate the benefits derived 
from this type of approach of cancer of the oral and 
maxillofacial region. 
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